Running head: TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 1
Use of Telemedicine in the Management of Patients with Diabetes Outline
Quadasia Dukes
Liberty University
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 2
I. Introduction
Diabetes is among the health conditions impacting millions of Americans.
In 2018, approximately 34.2 million Americans had diabetes, accounting for 10.5 percent
of the entire population.
Most patients with diabetes lack a primary care provider or lack complete access to one,
particularly those living in rural areas.
As the population continues to grow, the population of uninsured people increases, and
the primary care resource become constrained.
o Eighty-one percent of the physicians in 2014 described themselves at full patient
capacity or overextended.
o It causes a shortage of regular healthcare provider
The introduction of telehealth will facilitate the provision of comprehensive, timely, and
quality care to diabetic patients (So & Chung, 2018).
II. Thesis Statement: With the shortage of primary healthcare professionals and the
increasing diabetic population with primary care access, telemedicine will be a perfect
strategy for managing patients with diabetes.
III. Application of telemedicine in the management of patients with diabetes
The majority of the diabetic patients lack access to primary health primary especially
those who are insured
With the growing number of the American becoming diabetic, it raises the demand for
specialty diabetes care
However, the US is experiencing a shortage of full-time specialists to provide diabetes
care, thus creating a disparity between diabetes management (DM) and specialty diabetes
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 3
The use of telemedicine will improve diabetes care management among the patients will
address the disparity between DM and specialty diabetes.
Xu, T., Pujara, S., Sutton, S., & Rhee, M. (2018). Peer-reviewed: Telemedicine in the
management of type 1 diabetes. Preventing chronic disease, 15.
o The article will be applied to explain the prevalence of diabetes in the country and
how the use of telemedicine to address the disparity between DM and specialty
diabetes.
o Polinski, J. M., Barker, T., Gagliano, N., Sussman, A., Brennan, T. A., & Shrank, W.
H. (2016). Patients’ satisfaction with and preference for telehealth visits. Journal of
general internal medicine, 31(3), 269-275.
o The article will be used to explain how telemedicine improves diabetic patients
satisfaction.
IV. Significance of use telemedicine in DM
The use of telemedicine will improve diabetes care accessibility, reduce cost, reduce time
waste and improve patient satisfaction and diabetes care management among the patients
will address the disparity between DM and specialty diabetes.
Telemedicine will support diabetes self-management activities like glucose tracking and
monitoring.
Lee, J. Y., & Lee, S. W. H. (2018). Telemedicine cost-effectiveness for diabetes
management: A systematic review. Diabetes technology & therapeutics, 20(7), 492-500.
o The article will be used to explain how telemedicine is reducing the cost of
accessing diabetes health services.
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 4
Zhai, Y. K., Zhu, W. J., Cai, Y. L., Sun, D. X., & Zhao, J. (2014). Clinical-and cost-
effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-
analysis. Medicine, 93(28).
The article will be used to underscore that telemedicine helps to reduce blood glucose and
reduces the cost required in seeking diabetic specialty care.
Wu, C., Wu, Z., Yang, L., Zhu, W., Zhang, M., Zhu, Q., ... & Pan, Y. (2018). Evaluation
of the clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-
analysis. Medicine, 97(43).
The source will be used to explain the impact of telemedicine in glycemic control
compared to usual care.
V. Resistance of Telemedicine
Telemedicine can be useful in DM, but patients are more likely to resist it due to the
following reasons.
o Internet connectivity
o Lack of proper hardware like computers and smartphones
o Lack of technological savviness
o Language barrier
Rho, M. J., Kim, H. S., Chung, K., & Choi, I. Y. (2015). Factors influencing the
acceptance of telemedicine for diabetes management. Cluster Computing, 18(1), 321-
331.
o It will be applied to explain the causes of the resistance to telemedicine use
among diabetic patients.
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 5
Ghosh, A., Dutta, K., Tyagi, K., Gupta, R., & Misra, A. (2020). Roadblock in the
application of telemedicine for diabetes management in India during the COVID19
pandemic. Diabetes& metabolic syndrome, 14(4), 577.
o The source will explain various factors that limit diabetic patients from using
telemedicine to access diabetes specialty care.
Ayatollahi, H., Mirani, N., Nazari, F., & Razavi, N. (2018). Iranian healthcare
professionals’ perspectives about factors influencing the use of telemedicine in diabetes
management. World journal of diabetes, 9(6), 92.
o The article will be applied to how healthcare practitioners' concerns impact the
implementation of telemedicine in DM. It is always important for the healthcare
organization to consider the health practitioners' concerns on its implementation.
VI. Conclusion
With the shortage of primary healthcare professionals and the increasing diabetic
population with primary care access, telemedicine will be a perfect strategy for managing
patients with diabetes.
o Telemedicine will improve the accessibility of diabetes care among diabetes patients
(Lee, Greenfield, & Pappas, 2018).
o It will reduce the cost of care among the diabetes patient
o It improves patient satisfaction as they can access healthcare services anytime and
anywhere
Use telemedicine is critical the diabetes self-management culture
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 6
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 7
References
Ayatollahi, H., Mirani, N., Nazari, F., & Razavi, N. (2018). Iranian healthcare professionals’
perspectives about factors influencing the use of telemedicine in diabetes
management. World journal of diabetes, 9(6), 92.
Ghosh, A., Dutta, K., Tyagi, K., Gupta, R., & Misra, A. (2020). Roadblock in the application of
telemedicine for diabetes management in India during the COVID19 pandemic. Diabetes
& metabolic syndrome, 14(4), 577.
Lee, J. Y., & Lee, S. W. H. (2018). Telemedicine cost-effectiveness for diabetes management: A
systematic review. Diabetes technology & therapeutics, 20(7), 492-500.
Polinski, J. M., Barker, T., Gagliano, N., Sussman, A., Brennan, T. A., & Shrank, W. H. (2016).
Patients’ satisfaction with and preference for telehealth visits. Journal of general internal
medicine, 31(3), 269-275.
Rho, M. J., Kim, H. S., Chung, K., & Choi, I. Y. (2015). Factors influencing the acceptance of
telemedicine for diabetes management. Cluster Computing, 18(1), 321-331.
Wu, C., Wu, Z., Yang, L., Zhu, W., Zhang, M., Zhu, Q., ... & Pan, Y. (2018). Evaluation of the
clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-
analysis. Medicine, 97(43).
Xu, T., Pujara, S., Sutton, S., & Rhee, M. (2018). Peer reviewed: Telemedicine in the
management of type 1 diabetes. Preventing chronic disease, 15
Zhai, Y. K., Zhu, W. J., Cai, Y. L., Sun, D. X., & Zhao, J. (2014). Clinical-and cost-effectiveness
of telemedicine in type 2 diabetes mellitus: a systematic review and meta-
analysis. Medicine, 93(28).
TELEMEDICINE IN THE DIABETES MANAGEMENT OUTLINE 8
So, C. F., & Chung, J. W. (2018). Telehealth for diabetes self-management in primary
healthcare: a systematic review and meta-analysis. Journal of telemedicine and
telecare, 24(5), 356-364.
Lee, P. A., Greenfield, G., & Pappas, Y. (2018). The impact of telehealth remote patient
monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis
of systematic reviews of randomized controlled trials. BMC health services
research, 18(1), 1-10.
